Cambridge Investment Research Advisors’s Avantis Short-Term Fixed Income ETF AVSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-5,744
Closed -$269K – 4052
2026
Q1
$269K Buy
+5,744
New +$270K ﹤0.01% 3390
2025
Q3
– Sell
-6,648
Closed -$313K – 3725
2025
Q2
$313K Sell
6,648
-753
-10% -$35.1K ﹤0.01% 2942
2025
Q1
$346K Buy
7,401
+1,227
+20% +$56.9K ﹤0.01% 2743
2024
Q4
$285K Hold
6,174
– – ﹤0.01% 2873
2024
Q3
$291K Sell
6,174
-400
-6% -$18.7K ﹤0.01% 2855
2024
Q2
$304K Buy
6,574
+1,500
+30% +$69K ﹤0.01% 2695
2024
Q1
$235K Sell
5,074
-260
-5% -$12K ﹤0.01% 2886
2023
Q4
$248K Buy
5,334
+585
+12% +$26.8K ﹤0.01% 2746
2023
Q3
$216K Hold
4,749
– – ﹤0.01% 2752
2023
Q2
$218K Buy
4,749
+409
+9% +$18.9K ﹤0.01% 2807
2023
Q1
$201K Sell
4,340
-474
-10% -$21.9K ﹤0.01% 2824
2022
Q4
$221K Buy
+4,814
New +$220K ﹤0.01% 2668

Other funds holding AVSF

Cambridge Investment Research Advisors's AVSF Position: Q2 2026 in Review

Cambridge Investment Research Advisors sold out of Avantis Short-Term Fixed Income ETF (AVSF) in Q2 2026, closing a stake of 5,744 shares — an estimated $269K sold.

Cambridge Investment Research Advisors first reported a position in AVSF in Q4 2022 and held it in 12 quarters. The position peaked at $346K in Q1 2025. 91 funds tracked by Wall St. Rank hold AVSF as of Q2 2026.

  • Cambridge Investment Research Advisors reported no remaining Avantis Short-Term Fixed Income ETF position as of Q2 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 5,744 Avantis Short-Term Fixed Income ETF shares in Q2 2026, an estimated $269K.
  • Cambridge Investment Research Advisors first reported a position in Avantis Short-Term Fixed Income ETF in Q4 2022 and held it in 12 quarters.
  • Cambridge Investment Research Advisors's Avantis Short-Term Fixed Income ETF position peaked at $346K in Q1 2025.
  • 91 funds tracked by Wall St. Rank held Avantis Short-Term Fixed Income ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.